KPIs & Operating Metrics(New)
Balance Sheet
Accumulated DepreciationAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReal Estate - GrossReal Estate - NetReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Global Medical REIT (GMRE) over the last 14 years, with Q3 2025 value amounting to $1.3 billion.

  • Global Medical REIT's Liabilities and Shareholders Equity rose 246.6% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 billion, marking a year-over-year increase of 161.81%. This contributed to the annual value of $1.3 billion for FY2024, which is 88.46% down from last year.
  • Latest data reveals that Global Medical REIT reported Liabilities and Shareholders Equity of $1.3 billion as of Q3 2025, which was up 246.6% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Global Medical REIT's Liabilities and Shareholders Equity peaked at $1.4 billion during Q3 2022, and registered a low of $1.1 billion during Q1 2021.
  • Its 5-year average for Liabilities and Shareholders Equity is $1.3 billion, with a median of $1.3 billion in 2025.
  • Per our database at Business Quant, Global Medical REIT's Liabilities and Shareholders Equity surged by 2414.71% in 2021 and then plummeted by 901.2% in 2023.
  • Over the past 5 years, Global Medical REIT's Liabilities and Shareholders Equity (Quarter) stood at $1.3 billion in 2021, then grew by 10.27% to $1.4 billion in 2022, then decreased by 9.01% to $1.3 billion in 2023, then decreased by 0.88% to $1.3 billion in 2024, then increased by 1.33% to $1.3 billion in 2025.
  • Its Liabilities and Shareholders Equity was $1.3 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.